These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 29627656)
21. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents. Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552 [TBL] [Abstract][Full Text] [Related]
22. Challenging inflammatory process at molecular, cellular and in vivo levels via some new pyrazolyl thiazolones. Elzahhar PA; Alaaeddine RA; Nassra R; Ismail A; Labib HF; Temraz MG; Belal ASF; El-Yazbi AF J Enzyme Inhib Med Chem; 2021 Dec; 36(1):669-684. PubMed ID: 33618602 [TBL] [Abstract][Full Text] [Related]
23. Novel pyrimidine-pyridine hybrids: Synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability. Abdelgawad MA; Bakr RB; Azouz AA Bioorg Chem; 2018 Apr; 77():339-348. PubMed ID: 29421710 [TBL] [Abstract][Full Text] [Related]
24. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165 [TBL] [Abstract][Full Text] [Related]
25. Synthesis, modeling and biological evaluation of some pyrazolo[3,4-d]pyrimidinones and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidinones as anti-inflammatory agents. Tageldin GN; Ibrahim TM; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM Bioorg Chem; 2019 Sep; 90():102844. PubMed ID: 31229797 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and molecular docking study of some substituted 4,5- dihydro-2H-indazole derivatives as potential anti-inflammatory agents. Badr MH; Elbayaa RY; El-Ashmawy IM Med Chem; 2013 Aug; 9(5):718-30. PubMed ID: 23061568 [TBL] [Abstract][Full Text] [Related]
28. New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study. El-Miligy MM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SA Future Med Chem; 2017 Apr; 9(5):443-468. PubMed ID: 28362117 [TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, characterization and in vitro and in vivo anti-inflammatory evaluation of novel pyrazole-based chalcones. Chavan HV; Adsul LK; Kotmale AS; Dhakane VD; Thakare VN; Bandgar BP J Enzyme Inhib Med Chem; 2015 Feb; 30(1):22-31. PubMed ID: 24666306 [TBL] [Abstract][Full Text] [Related]
30. Novel 4-methylsulfonylphenyl derivatives as NSAIDS with preferential COX-2 inhibition. Amin NH; Mohammed AA; Abdellatif KR Future Med Chem; 2018 Jan; 10(1):53-70. PubMed ID: 29235887 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of novel pyrazole derivatives as anti-inflammatory antimicrobial agents. Bekhit AA; Ashour HM; Bekhit Ael-D; Bekhit SA Med Chem; 2009 Mar; 5(2):103-17. PubMed ID: 19275709 [TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, cyclooxygenase inhibition and biological evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing amino/methanesulfonyl pharmacophore. Abdellatif KR; Fadaly WA Bioorg Chem; 2017 Feb; 70():57-66. PubMed ID: 27894776 [TBL] [Abstract][Full Text] [Related]
33. Synthesis of new pyrazoles and pyrozolo [3,4-b] pyridines as anti-inflammatory agents by inhibition of COX-2 enzyme. Mohamed LW; Shaaban MA; Zaher AF; Alhamaky SM; Elsahar AM Bioorg Chem; 2019 Mar; 83():47-54. PubMed ID: 30342385 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents. Ahmed EM; Kassab AE; El-Malah AA; Hassan MSA Eur J Med Chem; 2019 Jun; 171():25-37. PubMed ID: 30904755 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities. Abd El Razik HA; Mroueh M; Faour WH; Shebaby WN; Daher CF; Ashour HMA; Ragab HM Chem Biol Drug Des; 2017 Jul; 90(1):83-96. PubMed ID: 28032452 [TBL] [Abstract][Full Text] [Related]
36. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential. Abd El Razik HA; Badr MH; Atta AH; Mouneir SM; Abu-Serie MM Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28418202 [TBL] [Abstract][Full Text] [Related]
37. New pyrazole derivatives: Synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES. Hassan GS; Abdel Rahman DE; Abdelmajeed EA; Refaey RH; Alaraby Salem M; Nissan YM Eur J Med Chem; 2019 Jun; 171():332-342. PubMed ID: 30928706 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme. El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504 [TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of some substituted 1H-pyrazolyl-thiazolo[4,5-d]pyrimidines as anti-inflammatory-antimicrobial Agents. Bekhit AA; Fahmy HT; Rostom SA; Baraka AM Eur J Med Chem; 2003 Jan; 38(1):27-36. PubMed ID: 12593914 [TBL] [Abstract][Full Text] [Related]
40. New celecoxib derivatives as anti-inflammatory agents. Szabó G; Fischer J; Kis-Varga A; Gyires K J Med Chem; 2008 Jan; 51(1):142-7. PubMed ID: 18072726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]